Skip to main content
. 2023 Jun 22;25(6):euad159. doi: 10.1093/europace/euad159

Figure 2.

Figure 2

Cost-effectiveness acceptability curves plots for the composite (mixed) population and per device type. CRT-D, cardiac resynchronization therapy defibrillator; CRT-P, cardiac resynchronization therapy pacemaker; QALY, quality-adjusted life year.